| INTRODUCTION
Naturally occurring hyperadrenocorticism (HAC) is a frequently diagnosed endocrine disorder in dogs. 1 The result of excessive ACTH secretion or ACTH-independent cortisol overproduction, HAC is characterized by a constellation of clinical signs and clinicopathological laboratory abnormalities. 1, 2 It is a common cause of dermatological lesions as well as polyuria, polydipsia, and polyphagia in dogs. [1] [2] [3] [4] Rarely, it may lead to serious potentially life-threatening complications, including thromboembolism, infections, and urolithiasis. [1] [2] [3] Treatment of HAC entails considerable financial expenses, and potentially serious adverse effects. On the other hand, withholding treatment may lead to exacerbation of clinical signs and increased risk of complications. [1] [2] [3] Both false positive and false negative test results are therefore a concern. Diagnosis of HAC is hindered by inadequate Abbreviations: BC, serum cortisol concentrations; PC, post-stimulation cortisol concentration; DeltaC, post-to-baseline cortisol concentrations difference; RatioC, post-to-baseline cortisol concentrations quotient; ACTHST, adrenocorticotropic hormone stimulation test; ACVIM, American College of Veterinary Internal Medicine; PDHAC, pituitary-dependent hyperadrenocorticism; AT, adrenal tumor; AUC, area under the ROC curve; CI, confidence interval; HAC, hyperadrenocorticism; LDDST, low-dose dexamethasone suppression test; NAI, non-adrenal illness; ROC, receiver operator characteristics sensitivities and specificities of existing diagnostic tests. 2, 3, [5] [6] [7] [8] [9] [10] Their performance, however, is greatly improved when performed on a population of dogs with compatible clinical signs and laboratory abnormalities. 8, 10 The ACTH stimulation test (ACTHST) often is advocated as the initial screening tool for dogs suspected of HAC because of its simplicity, short duration, and higher specificity and positive predictive value. 7, 10 However, in the latest American College of Veterinary Inter- When cases could not be classified as HAC or NAI by the abovementioned criteria, they were independently re-evaluated by each of the reviewers and subsequently included only if the 2 reviewers concurred.
| Statistical analyses
Descriptive statistics are presented as medians and range. Frequencies of clinical signs, imaging findings, and clinicopathological data were compared between dogs with HAC or NAI using Fisher's exact test.
Receiver operator characteristics (ROC) analyses were used to assess the predictive accuracy of BC alone, PC alone, DeltaC, and were overrepresented in dogs with PDHAC (Table 1) . Similarly, many clinicopathological derangements were observed equally in both dogs with PDHAC and NAI, except for hypercholesterolemia that was more frequently observed in dogs with PDHAC (Table 2) . Adrenal size was not significantly different between dogs with PDHAC and NAI The frequencies of an increased BC or a RatioC exceeding 2 were not significantly different between dogs with PDHAC or NAI (69% versus 56%; P = .50 and 97% versus 89%; P = .40, respectively). The frequency of an increased PC was significantly higher in dogs with a final diagnosis of PDHAC compared to dogs with NAI (92% versus 39%; P = .0001).
The AUC of PC for a final diagnosis of PDHAC was significantly higher than all other AUCs excluding DeltaC (Figure 1 , Table 3 ). Sam- Sensitivity and specificity for the optimal cutoff value of PC (>683 nmol/L or >24.8 μg/dL) were 86% and 94%, respectively. The lower traditional cutoff value (>550 nmol/L or >19.9 μg/dL) yielded a sensitivity of 92% and a specificity of 61%, whereas a higher cutoff value of (>718 nmol/L or 26.0 μg/dL) yielded a sensitivity of 81% with a specificity of 100%.
| DISCUSSION
In our study, BC provided no added value in the interpretation of the ACTHST for a diagnosis of PDHAC, as neither the difference nor the ratio between PC and BC improved the diagnostic accuracy of the ACTHST in predicting a final diagnosis of PDHAC compared to PC alone. As expected, BC alone was ineffective in the diagnosis of PDHAC. The ACTHST and the LDDST are commonly used as screening tests for HAC in dogs. 1, 3 The former test is based on identifying excessive cortisol secretion in response to exogenous ACTH. Its sensitivity varies among studies, is higher in PDHAC compared to functional ATs, and ranges between 57 and 95%. [1] [2] [3] 7, 9, 10 The LDDST test is based on identifying decreased sensitivity of the hypothalamicpituitary-adrenal axis to negative feedback by exogenous glucocorticoids. Despite better sensitivity (85%-100%), the test lacks specificity (44%-73%). [1] [2] [3] 7, 10, 11 The ACTHST is considered superior to LDDST in terms of simplicity and specificity. 7, 10 Therefore, it frequently is used as a screening test in the diagnosis of HAC. Furthermore, it is commonly used in monitoring response to treatment, 1 in addition to newly introduced approaches employing BC for monitoring trilostane treatment. 17 Current guidelines regarding the technical aspects of performing the ACTHST, including the latest ACVIM consensus statement on the diagnosis of spontaneous HAC, recommend collection of both baseline and post-stimulation samples. 1, 3 Notwithstanding the above, current guidelines regarding the interpretation of the ACTHST results are solely concerned with PC, when PC exceeding 550-600 nmol/L (19.9-21.7 μg/dL) often are considered positive. 1, 7, 10, 11 To the best of our knowledge, only a single veterinary textbook refers to the futility of BC in the diagnosis of spontaneous HAC, regarding the practice as a "habit" and "not informative." 18 Owing to its pivotal role in maintaining various physiological functions, as well as the body's response to stressful events, serum cortisol concentrations commonly fluctuate during the day in response to a plethora of physical, inflammatory, neurogenic, and emotional stimuli. 4, [12] [13] [14] Unlike humans, a circadian rhythm in cortisol secretion has not been consistently identified in dogs, but pulsatile cortisol secretion is common, as a result of episodic secretion of ACTH. [12] [13] [14] Furthermore, dogs with HAC also have episodic cortisol secretion and consequently may have BC within the reference range. 2, 7 Therefore, BC is neither sensitive nor specific in the diagnosis of spontaneous HAC, 2, 4, 7 and previous studies as well as ours failed to find statistically significant differences in BC between dogs with spontaneous HAC and dogs with NAI. 2, 5, 8, 9 Although the absolute result of BC was uncommonly addressed by general practitioners in a preliminary survey conducted by us, the majority used both measurements in result interpretation including DeltaC and RatioC. To the best of our knowledge, no references for such calculations and their interpretation exist in the veterinary literature, except for a reference in which a post-tobaseline cortisol ratio of >2 in urinary 17-ketogenic steroids after the ACTHST was regarded as confirmatory for adrenocortical hyperplasia. 19 In our study, no statistically significant differences in the proportion of increased RatioC (ie, >2) in the blood were found between dogs diagnosed with spontaneous PDHAC and those in which the disease had been ruled out.
Two medical conditions require BC measurement when performing the ACTHST. The first is iatrogenic HAC, where both baseline and post-stimulation measurements are used to confirm adrenal Employing a conventional cutoff point of 550 nmol/L (19.9 μg/dL) 7,10 yielded a comparably low specificity (61%), in contrast to the perception of the ACTHST as a relatively specific test. 1 The optimal higher cutoff value (683 nmol/L or 24.8 μg/dL) yielded a much higher specificity (94%), while moderately compromising the sensitivity of the test (86%). A specificity of 100% was reached with an even higher cutoff value (718 nmol/L or 26.0 μg/dL), which resulted in a lower sensitivity of (81%). These cutoff values may be helpful for interpretation of the ACTHST.
The stringent selection criteria for performing the ACTHST probably improved its performance in this study. These criteria were based on inclusion of dogs with compatible clinical findings according to the ACVIM consensus statement. 3 In addition, the exclusion of dogs with AT most likely also contributed to the higher sensitivity of the ACTHST in our study, because lower sensitivity of the test is reported in such cases. 1 In conclusion, PC had good-to-excellent discriminatory power for a final diagnosis of PDHAC, which was comparable to DeltaC whereas BC and RatioC failed to discriminate between PDHAC and NAI.
Therefore, there is no apparent added value in obtaining prestimulation BC for interpretation of the ACTHST in the diagnosis of spontaneous PDHAC. Additional studies are required to investigate the performance of the ACTHST in cases of HAC caused by functional AT.
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